Evoke Wealth’s Zomedica Corp. ZOM Stock Holding History

Evoke Wealth’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-33	Closed	–	–	1237
2022 Q3	$0	Hold	33	–	–	﹤0.01%	1310
2022 Q2	$0	Buy	+33	New	+$8	﹤0.01%	1289

Other funds holding ZOM

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Evoke Wealth's ZOM Position: Q4 2022 in Review

Evoke Wealth sold out of Zomedica Corp. (ZOM) in Q4 2022, closing a stake of 33 shares.

Evoke Wealth first reported a position in ZOM in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 91 funds tracked by Wall St. Rank hold ZOM as of Q4 2022.

Evoke Wealth reported no remaining Zomedica Corp. position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 33 Zomedica Corp. shares in Q4 2022.
Evoke Wealth first reported a position in Zomedica Corp. in Q2 2022 and held it in 2 quarters.
Evoke Wealth's Zomedica Corp. position peaked at $0 in Q3 2022.
91 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.